| The case for personalized medicine. | |
| | |
MedLine Citation:
|
PMID: 20144313 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Personalized medicine may be considered an extension of traditional approaches to understanding and treating disease, but with greater precision. Physicians may now use a patient's genetic variation or expression profile as well as protein and metabolic markers to guide the selection of certain drugs or treatments. In many cases, the information provided by molecular markers predicts susceptibility to conditions. The added precision introduces the possibility of a more preventive, effective approach to clinical care and reductions in the duration and cost of clinical trials. Here, we make the case, through real-world examples, that personalized medicine is delivering significant value to individuals, to industry, and to the health care system overall and that it will continue to grow in importance if we can lift the barriers that impede its adoption and build incentives to encourage its practice. |
| | |
Authors:
|
Edward Abrahams; Mike Silver |
Related Documents
:
|
22556843 - Ayurvedic rationale of the southern indian vegetable soup saaru or rasam. 18189953 - Effects of clear speech on duration and fundamental frequency of vowels produced by mon... 18074893 - Increasing conservation management action by involving local people in natural resource... |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-07-01 |
Journal Detail:
|
Title: Journal of diabetes science and technology Volume: 3 ISSN: 1932-2968 ISO Abbreviation: J Diabetes Sci Technol Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2010-02-10 Completed Date: 2010-06-02 Revised Date: 2011-03-11 |
Medline Journal Info:
|
Nlm Unique ID: 101306166 Medline TA: J Diabetes Sci Technol Country: United States |
Other Details:
|
Languages: eng Pagination: 680-4 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 Diabetes Technology Society. |
Affiliation:
|
Personalized Medicine Coalition, Washington, DC 20005, USA. eabrahams@personalizedmedicinecoalition.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Genome, Human Humans Individualized Medicine* Patient Compliance Pharmacogenetics* |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The personalized medicine for diabetes meeting summary report.
Next Document: Genetics factors contributing to type 2 diabetes across ethnicities.